CC49 humanized radioimmunoconjugates (National Cancer Institute, University of Alabama at Birmingham)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameCC49 humanized radioimmunoconjugates (National Cancer Institute, University of Alabama at Birmingham)

Drug Alias NameCC49 humanized radioimmunoconjugates (NCI, UAB)HuCC49deltaCH2 (NCI, UAB)HuCC49deltaCH2 (National Cancer Institute, University of Alabama at Birmingham)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesNational Cancer Institute

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesNational Cancer Institute University Of Alabama At Birmingham

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A